Based on our results, we suggest that other polymorphisms of the studied genes (BCL2, CASP3, CASP9, and TP53) may be associated with breast cancer, or that studies polymorphisms should be carried out in larger cohorts. This evidence concerns the gene TP53 and breast carcinoma.